These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32812132)

  • 21. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Cheung CMG; Yanagi Y; Akiba M; Tan A; Mathur R; Chan CM; Yeo I; Wong TY
    Retina; 2019 Sep; 39(9):1655-1663. PubMed ID: 29927796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.
    Alasil T; Ferrara D; Adhi M; Brewer E; Kraus MF; Baumal CR; Hornegger J; Fujimoto JG; Witkin AJ; Reichel E; Duker JS; Waheed NK
    Am J Ophthalmol; 2015 Apr; 159(4):634-43. PubMed ID: 25528955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Shen YS; Cheng CK
    Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHOROIDAL VASCULAR ALTERATIONS IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Cheung CMG; Wong MYZ; Teo KYC
    Retina; 2023 Jan; 43(1):1-7. PubMed ID: 36542080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
    Ogasawara M; Koizumi H; Yamamoto A; Itagaki K; Saito M; Maruko I; Okada AA; Iida T; Sekiryu T
    Jpn J Ophthalmol; 2018 Sep; 62(5):584-591. PubMed ID: 29974277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polypoidal choroidal vasculopathy].
    Yuzawa M
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy.
    Sayanagi K; Gomi F; Akiba M; Sawa M; Hara C; Nishida K
    Br J Ophthalmol; 2015 Jan; 99(1):29-35. PubMed ID: 25107899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
    Sakurada Y; Nakamura Y; Yoneyama S; Mabuchi F; Gotoh T; Tateno Y; Sugiyama A; Kubota T; Iijima H
    Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration.
    Lorentzen TD; Subhi Y; Sørensen TL
    Acta Ophthalmol; 2018 Aug; 96(5):475-480. PubMed ID: 29193780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of Neovascular Age-Related Macular Degeneration in Brazilian Patients.
    Pereira FB; Veloso CE; Kokame GT; Nehemy MB
    Ophthalmologica; 2015; 234(4):233-42. PubMed ID: 26394133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
    Shin JY; Choi M; Chung B; Byeon SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicolour imaging for the detection of polypoidal choroidal vasculopathy and age-related macular degeneration.
    Tan CS; Ting DS; Lim LW
    Clin Exp Ophthalmol; 2019 Jul; 47(5):621-630. PubMed ID: 30578655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
    Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lateral elongation of flat irregular pigment epithelial detachment: A novel optical coherence tomography biomarker in polypoidal choroidal vasculopathy.
    Alex D; Giridhar A; Gopalakrishnan M; Indu VP
    Indian J Ophthalmol; 2020 Jan; 68(1):134-140. PubMed ID: 31856491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.
    Chaikitmongkol V; Upaphong P; Patikulsila D; Jirarattanasopa P; Choovuthayakorn J; Watanachai N; Kunavisarut P; Ratanasukon M; Bhurayanontachai P; Ingviya T; Bressler SB; Bressler NM
    Ophthalmol Retina; 2022 Jan; 6(1):21-28. PubMed ID: 33781929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy.
    Cheung CM; Li X; Mathur R; Lee SY; Chan CM; Yeo I; Loh BK; Williams R; Wong EY; Wong D; Wong TY
    PLoS One; 2014; 9(6):e101057. PubMed ID: 24978485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.